ReviewTherapeutic advances in respiratory disease2014

Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis.

Chris Stockmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.